Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
What has been documented from these sources includes: Headaches, typically described as dull and short-lived Dizziness or light-headedness, particularly after injection Nausea or mild digestive discomfort, more common with oral forms Injection-site reactions including redness, swelling and irritation Appetite changes, sometimes reported as increased hunger Disrupted sleep when dosed in the evening Less commonly, palpitations or mood changes None of these has been formally linked to BPC-157 in peer-reviewed human studies
Created using data from Prime Therapeutic's study
Gastrointestinal (GI) side effects are common in people with diabetes treated both with metformin and with GLP-1 receptor agonists (GLP-1 RAs), and they are the commonest reason for discontinuation of these drugs in clinical practice
Efficiency IV therapy is more efficient than oral supplements
Take control of your health and book your first NAD+ IV Therapy session today
